Key Highlights of Totipro® Postbiotic PE0401

Totipro® Postbiotic PE0401 is a postbiotic ingredient developed by Glac Biotech. It is the winner of the prestigious "NutraIngredients-Asia Award for Microbiome Modulation," an honor often called the "Oscars of the dietary supplement industry." This achievement marks it as not only the first ingredient in Asia to win this award but also the world's first postbiotic health ingredient to be honored in any of the six major functional categories by NutraIngredients.

Composition and Features

• Unique Probiotic Strain Combination: This ingredient is the world's only postbiotic created from a unique blend of four probiotic strains: Lactobacillus salivarius AP-32, Lactobacillus acidophilus TYCA06, Lactobacillus plantarum LPL28, and Bifidobacterium longum subsp. infantis BLI-02.

• Golden Fermentation Process: It is produced through a proprietary 48-hour natural "golden fermentation" process.

• Enhanced Gut Function: Validated by in-vitro, animal, and human studies, it has demonstrated a superior ability to bind with intestinal proteins compared to single-strain postbiotics, thereby promoting the integrity of the intestinal mucosal lining.

• Developed for Inflammatory Response: This product was specifically developed by Glac Biotech to help address inflammation in the human body.

Proven Health Benefits

• Contains a variety of enzymes that break down nutrients, aiding intestinal absorption and reducing digestive discomfort.

• Strengthens the intestinal epithelial barrier and helps optimize the gut microbiota.

• Supports healthy bowel regulation, helping to alleviate diarrhea and promote regularity.

• Helps regulate physiological and immune functions to produce beneficial health effects within the body.

• Meets food safety and hygiene standards, with comprehensive data supporting its safety and stability.
   

Global Patents and Awards

• Global Patent Protection: The ingredient's efficacy is protected by global patents in regions including the United States, China, the EU, and Taiwan. These patents cover its antioxidant properties, its ability to promote the growth of beneficial bacteria, and its benefits for bowel regularity.

• Published in International Journals: It has been featured in several international SCI-indexed scientific journals.

• Additional Awards and Honors: In addition to the NutraIngredients Award, it has received the Lactobacillus Association's Innovation Award, the National Innovation Award (Taiwan), and the Innovative Raw Material Award from Nutrition Manufacturing (China).

• Global Business Presence: Our business presence for this ingredient spans five continents.

About the Developer: Glac Biotech

Glac Biotech is a leading global brand in the probiotics industry. The company leverages its exclusive probiotic function validation platform and its high-density PRONEX® production technology. Through its PRIMETEK® service, it offers a vertically integrated, end-to-end industry chain—from custom probiotic powder formulation to final product sales—providing clients with a one-stop solution. Beyond PE0401, Glac Biotech has also developed Totipro® Postbiotic PE0301, which is designed for gastric and oral health applications.